104 related articles for article (PubMed ID: 23205865)
1. Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia.
Lai J; Pinas A; Syngelaki A; Poon LC; Nicolaides KH
J Matern Fetal Neonatal Med; 2013 May; 26(8):733-7. PubMed ID: 23205865
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30-33 weeks in the prediction of preeclampsia.
Mosimann B; Wagner M; Birdir C; Poon LC; Nicolaides KH
J Matern Fetal Neonatal Med; 2013 May; 26(8):763-7. PubMed ID: 23205868
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia.
Lai J; Syngelaki A; Poon LC; Nucci M; Nicolaides KH
Fetal Diagn Ther; 2013; 33(3):149-55. PubMed ID: 23154616
[TBL] [Abstract][Full Text] [Related]
4. Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation.
Banzola I; Farina A; Concu M; Sekizawa A; Purwosunu Y; Strada I; Arcelli D; Simonazzi G; Caramelli E; Rizzo N
Prenat Diagn; 2007 Nov; 27(11):1005-10. PubMed ID: 17654753
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
6. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum placental growth factor, pregnancy-associated plasma protein-a and free β-human chorionic gonadotrophin at 30-33 weeks in the prediction of pre-eclampsia.
Lai J; Pinas A; Poon LC; Agathokleous M; Nicolaides KH
Fetal Diagn Ther; 2013; 33(3):164-72. PubMed ID: 23445908
[TBL] [Abstract][Full Text] [Related]
8. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.
Akolekar R; Syngelaki A; Beta J; Kocylowski R; Nicolaides KH
Prenat Diagn; 2009 Dec; 29(12):1103-8. PubMed ID: 19777530
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum vitamin D levels at 11-13 weeks of gestation in preeclampsia.
Yu CK; Ertl R; Skyfta E; Akolekar R; Nicolaides KH
J Hum Hypertens; 2013 Feb; 27(2):115-8. PubMed ID: 22336906
[TBL] [Abstract][Full Text] [Related]
11. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia.
Poon LC; Maiz N; Valencia C; Plasencia W; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jan; 33(1):23-33. PubMed ID: 19090499
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum anti-Müllerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia.
Birdir C; Fryze J; Vasiliadis H; Nicolaides KH; Poon LC
J Matern Fetal Neonatal Med; 2015 May; 28(8):865-8. PubMed ID: 24953352
[TBL] [Abstract][Full Text] [Related]
13. Systolic, diastolic and mean arterial pressure at 30-33 weeks in the prediction of preeclampsia.
Lai J; Poon LC; Bakalis S; Chiriac R; Nicolaides KH
Fetal Diagn Ther; 2013; 33(3):173-81. PubMed ID: 23328077
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11-13 weeks in preeclampsia.
Sifakis S; Akolekar R; Kappou D; Mantas N; Nicolaides KH
J Hum Hypertens; 2012 Apr; 26(4):253-8. PubMed ID: 21368777
[TBL] [Abstract][Full Text] [Related]
15. Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks' gestation.
Gallo D; Poon LC; Fernandez M; Wright D; Nicolaides KH
Fetal Diagn Ther; 2014; 36(1):28-37. PubMed ID: 24752037
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum cytokines at 30-33 weeks in the prediction of preeclampsia.
Mosimann B; Wagner M; Poon LC; Bansal AS; Nicolaides KH
Prenat Diagn; 2013 Sep; 33(9):823-30. PubMed ID: 23591998
[TBL] [Abstract][Full Text] [Related]
17. First trimester levels of inhibins and activin A in normal and failing pregnancies.
Wallace EM; Marjono B; Tyzack K; Tong S
Clin Endocrinol (Oxf); 2004 Apr; 60(4):484-90. PubMed ID: 15049964
[TBL] [Abstract][Full Text] [Related]
18. Activin A and activin receptors in gestational tissue from preeclamptic pregnancies.
Manuelpillai U; Schneider-Kolsky M; Dole A; Wallace EM
J Endocrinol; 2001 Oct; 171(1):57-64. PubMed ID: 11572790
[TBL] [Abstract][Full Text] [Related]
19. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia.
Florio P; Reis FM; Pezzani I; Luisi S; Severi FM; Petraglia F
Ultrasound Obstet Gynecol; 2003 Feb; 21(2):165-9. PubMed ID: 12601840
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum alpha-fetoprotein at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia.
Bredaki FE; Matalliotakis M; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Apr; 47(4):466-71. PubMed ID: 26582719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
